Aimovig and Deep venous thrombosis - a phase IV clinical study of FDA data

Summary:

Deep venous thrombosis is reported as a side effect among people who take Aimovig (erenumab-aooe), especially for people who are female, 50-59 old, have been taking the drug for 6 - 12 months also take Botox, and have Migraine.

The phase IV clinical study analyzes which people have Deep venous thrombosis when taking Aimovig. It is created by eHealthMe based on reports of 49,844 people who have side effects when taking Aimovig from the FDA, and is updated regularly.

What is Aimovig?

Aimovig has active ingredients of erenumab-aooe. eHealthMe is studying from 49,930 Aimovig users. Check the latest studies of Aimovig.

What is Deep venous thrombosis?

Deep venous thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis) is found to be associated with 2,065 drugs and 2,967 conditions by eHealthMe. Check the latest studies of Deep venous thrombosis.

On Aug, 08, 2026

49,844 people reported to have side effects when taking Aimovig.
Among them, 17 people (0.03%) have Deep venous thrombosis.

Could Aimovig cause Deep venous thrombosis?

Among these 17 people:

How long have people been on Aimovig when they have Deep venous thrombosis? *

What is the gender of people who have Deep venous thrombosis when taking Aimovig? *

female: 100 %
male: 0.0 %

What is the age of people who have Deep venous thrombosis when taking Aimovig? *

What are other drugs people take besides Aimovig? *

What are other side effects people have besides Deep venous thrombosis? *

Pulmonary Embolism (blockage of the main artery of the lung): 6 people, 35.29%
Wound: 2 people, 11.76%
Drug Ineffective: 2 people, 11.76%
Fever: 2 people, 11.76%
Headache (pain in head): 2 people, 11.76%
High Blood Pressure: 2 people, 11.76%
Immunodeficiency Disorders: 2 people, 11.76%
Injection Site Pain: 2 people, 11.76%
Itching: 2 people, 11.76%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 2 people, 11.76%

What are the existing conditions these people have? *

Migraine (headache): 14 people, 82.35%
Restless Leg Syndrome (a powerful urge to move your legs): 2 people, 11.76%
Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 2 people, 11.76%
Pain: 1 person, 5.88%
Muscle Spasms (muscle contraction): 1 person, 5.88%
Birth Control: 1 person, 5.88%
Affective Disorder (mental disorder): 1 person, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Aimovig and have Deep venous thrombosis?

- Check whether Deep venous thrombosis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Aimovig:

Aimovig (49,930 reports)

Browse all side effects of Aimovig:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Deep venous thrombosis:

Deep venous thrombosis (2,065 drugs)

Browse all the conditions that are associated with Deep venous thrombosis:

Deep venous thrombosis (2,967 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on erenumab-aooe (the active ingredients of Aimovig) and Aimovig (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.